Guosheng Yin

ResearcherID HKU ResearcherPage Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Top Venues

Statistical methods in medical research

Pharmaceutical statistics

Statistics in medicine

BMC medical research methodology

This page only lists publications with an associated author ORCID identifier.

Publications

Jialu Fang, Guosheng Yin
Fractional accumulative calibration-free odds (f-aCFO) design for delayed toxicity in phase I clinical trials. Statistics in medicine 43 (17) (2024)
Jialu Fang, Guosheng Yin
Fractional accumulative calibration-free odds (f-aCFO) design for delayed toxicity in phase I clinical trials. Statistics in medicine (2024)
Jiaqi Gu, Guosheng Yin
Unit information Dirichlet process prior. Biometrics 80 (3) (2024)
Hengtao Zhang, Wen Su, Guosheng Yin
Quasi-rerandomization for observational studies. BMC medical research methodology 23 (1) (2023)
Huaqing Jin, Guosheng Yin
Time-to-event calibration-free odds design: A robust efficient design for phase I trials with late-onset outcomes. Pharmaceutical statistics (2023)
Hengtao Zhang, Wen Su, Guosheng Yin
Quasi-rerandomization for observational studies. BMC medical research methodology 23 (1) (2023)
Hengtao Zhang, Guosheng Yin
Unit information prior for incorporating real-world evidence into randomized controlled trials. Statistical methods in medical research 32 (2) (2023)
Hengtao Zhang, Guosheng Yin
Unit information prior for incorporating real-world evidence into randomized controlled trials. Statistical methods in medical research 32 (2) (2023)
Jiaqi Gu, Yiwei Fan, Guosheng Yin
Omnibus test for restricted mean survival time based on influence function. Statistical methods in medical research (2023)
Huaqing Jin, Guosheng Yin
Time-to-event calibration-free odds design: A robust efficient design for phase I trials with late-onset outcomes. Pharmaceutical statistics (2023)
Hengtao Zhang, Wen Su, Guosheng Yin
Quasi-rerandomization for observational studies. BMC medical research methodology 23 (1) (2023)
Hengtao Zhang, Guosheng Yin
Unit information prior for incorporating real-world evidence into randomized controlled trials. Statistical methods in medical research 32 (2) (2023)
Huaqing Jin, Guosheng Yin
Time-to-event calibration-free odds design: A robust efficient design for phase I trials with late-onset outcomes. Pharmaceutical statistics (2023)
Hengtao Zhang, Guosheng Yin
Unit information prior for incorporating real-world evidence into randomized controlled trials. Statistical methods in medical research 32 (2) (2023)
Huaqing Jin, Guosheng Yin
CFO: Calibration-free odds design for phase I/II clinical trials. Statistical methods in medical research 31 (6) (2022)
Chenyang Zhang, Guosheng Yin
Bayesian nonparametric analysis of restricted mean survival time. Biometrics (2022)
Huaqing Jin, Wenbin Du, Guosheng Yin
Approximate Bayesian computation design for phase I clinical trials. Statistical methods in medical research 31 (12) (2022)
Chenyang Zhang, Guosheng Yin
Reduction in number to treat versus number needed to treat. BMC medical research methodology 21 (1) (2021)
Huaqing Jin, Guosheng Yin
Unit information prior for adaptive information borrowing from multiple historical datasets. Statistics in medicine 40 (25) (2021)
Teng Zhang, Zhao Yang, Guosheng Yin
Dynamic ordering design for dose finding in drug-combination trials. Pharmaceutical statistics 20 (2) (2020)
Haolun Shi, Teng Zhang, Guosheng Yin
START: single-to-double arm transition design for phase II clinical trials. Pharmaceutical statistics 19 (4) (2020)
Guosheng Yin, Huaqing Jin
Comparison of Transmissibility of Coronavirus Between Symptomatic and Asymptomatic Patients: Reanalysis of the Ningbo COVID-19 Data. JMIR public health and surveillance 6 (2) (2020)
Guosheng Yin, Chenyang Zhang, Huaqing Jin
Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir. JMIR public health and surveillance 6 (3) (2020)
Huaqing Jin, Guosheng Yin
Bayesian enhancement two-stage design with error control for phase II clinical trials. Statistics in medicine 39 (29) (2020)
Chenyang Zhang, Yuanshan Wu, Guosheng Yin
Restricted mean survival time for interval-censored data. Statistics in medicine 39 (26) (2020)
Haolun Shi, Guosheng Yin
Bayesian enhancement two-stage design for single-arm phase II clinical trials with binary and time-to-event endpoints. Biometrics 74 (3) (2018)